{"data":[{"accessionNo":"0000902219-26-000255","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001061983","issuerName":"Cytokinetics, Incorporated","ticker":"CYTK","cusip":"23282W605","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Wellington Management Group LLP","reportingCik":null,"personType":"HC","sharesOwned":7116724,"percentOfClass":5.1,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/cytk"},{"accessionNo":"0000902219-26-000255","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001061983","issuerName":"Cytokinetics, Incorporated","ticker":"CYTK","cusip":"23282W605","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Wellington Group Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":7116724,"percentOfClass":5.1,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/cytk"},{"accessionNo":"0000902219-26-000255","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001061983","issuerName":"Cytokinetics, Incorporated","ticker":"CYTK","cusip":"23282W605","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Wellington Investment Advisors Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":7116724,"percentOfClass":5.1,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/cytk"},{"accessionNo":"0000315066-26-001467","formType":"SCHEDULE 13G/A","amendmentNo":8,"issuerCik":"0001061983","issuerName":"CYTOKINETICS INC","ticker":"CYTK","cusip":"23282W605","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":5248579.71,"percentOfClass":3.9,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/cytk"},{"accessionNo":"0000315066-26-001467","formType":"SCHEDULE 13G/A","amendmentNo":8,"issuerCik":"0001061983","issuerName":"CYTOKINETICS INC","ticker":"CYTK","cusip":"23282W605","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":5248579.71,"percentOfClass":3.9,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/cytk"},{"accessionNo":"0000315066-26-001169","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001061983","issuerName":"CYTOKINETICS INC","ticker":"CYTK","cusip":"23282W605","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":11135192.23,"percentOfClass":9,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/cytk"},{"accessionNo":"0000315066-26-001169","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001061983","issuerName":"CYTOKINETICS INC","ticker":"CYTK","cusip":"23282W605","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":11135192.23,"percentOfClass":9,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/cytk"},{"accessionNo":"0002100119-26-000377","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001061983","issuerName":"Cytokinetics Inc","ticker":"CYTK","cusip":"23282W605","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":6422042,"percentOfClass":5.21,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/cytk"},{"accessionNo":"0000102909-26-001049","formType":"SCHEDULE 13G/A","amendmentNo":11,"issuerCik":"0001061983","issuerName":"Cytokinetics Inc","ticker":"CYTK","cusip":"23282W605","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26","canonicalUrl":"https://xoomar.com/markets/stocks/cytk"},{"accessionNo":"0001897612-26-000261","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001061983","issuerName":"CYTOKINETICS INC","ticker":"CYTK","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":17716372,"percentOfClass":14.5,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/cytk"},{"accessionNo":"0001897612-25-000526","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001061983","issuerName":"CYTOKINETICS INC","ticker":"CYTK","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":19097373,"percentOfClass":16,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/cytk"},{"accessionNo":"0000093751-25-000596","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001061983","issuerName":"CYTOKINETICS INC","ticker":"CYTK","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"STATE STREET CORPORATION","reportingCik":null,"personType":"HC","sharesOwned":5617334,"percentOfClass":4.7,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/cytk"}],"updatedAt":"2026-10-29T06:14:10.809Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/cytk","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}